KR970005179B1 - (사이클로알킬아미노)메틸렌비스(포스폰산) 및 활성 성분으로서 이를 함유하는 약제 - Google Patents

(사이클로알킬아미노)메틸렌비스(포스폰산) 및 활성 성분으로서 이를 함유하는 약제 Download PDF

Info

Publication number
KR970005179B1
KR970005179B1 KR1019890000568A KR890000568A KR970005179B1 KR 970005179 B1 KR970005179 B1 KR 970005179B1 KR 1019890000568 A KR1019890000568 A KR 1019890000568A KR 890000568 A KR890000568 A KR 890000568A KR 970005179 B1 KR970005179 B1 KR 970005179B1
Authority
KR
South Korea
Prior art keywords
methylenebis
phosphonic acid
lower alkyl
cycloalkylamino
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
KR1019890000568A
Other languages
English (en)
Korean (ko)
Other versions
KR890011601A (ko
Inventor
야수오 이소무라
마코또 다께우찌
사카모또
테쭈시 아베
Original Assignee
야마노우찌 야꾸힝고교 가부시끼가이샤
모리오가 시게오
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 야마노우찌 야꾸힝고교 가부시끼가이샤, 모리오가 시게오 filed Critical 야마노우찌 야꾸힝고교 가부시끼가이샤
Publication of KR890011601A publication Critical patent/KR890011601A/ko
Application granted granted Critical
Publication of KR970005179B1 publication Critical patent/KR970005179B1/ko
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3839—Polyphosphonic acids
    • C07F9/3873—Polyphosphonic acids containing nitrogen substituent, e.g. N.....H or N-hydrocarbon group which can be substituted by halogen or nitro(so), N.....O, N.....S, N.....C(=X)- (X =O, S), N.....N, N...C(=X)...N (X =O, S)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40—Esters thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40—Esters thereof
    • C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4025—Esters of poly(thio)phosphonic acids
    • C07F9/405—Esters of poly(thio)phosphonic acids containing nitrogen substituent, e.g. N.....H or N-hydrocarbon group which can be substituted by halogen or nitro(so), N.....O, N.....S, N.....C(=X)- (X =O, S), N.....N, N...C(=X)...N (X =O, S)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
KR1019890000568A 1988-01-20 1989-01-20 (사이클로알킬아미노)메틸렌비스(포스폰산) 및 활성 성분으로서 이를 함유하는 약제 Expired - Lifetime KR970005179B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP11656/1988 1988-01-20
JP63-11656 1988-01-20
JP1165688 1988-01-20

Publications (2)

Publication Number Publication Date
KR890011601A KR890011601A (ko) 1989-08-21
KR970005179B1 true KR970005179B1 (ko) 1997-04-14

Family

ID=11784011

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019890000568A Expired - Lifetime KR970005179B1 (ko) 1988-01-20 1989-01-20 (사이클로알킬아미노)메틸렌비스(포스폰산) 및 활성 성분으로서 이를 함유하는 약제

Country Status (14)

Country Link
US (2) US4970335A (enExample)
EP (1) EP0325482B1 (enExample)
KR (1) KR970005179B1 (enExample)
CN (1) CN1022630C (enExample)
AT (1) ATE74361T1 (enExample)
AU (1) AU615711B2 (enExample)
CA (1) CA1339805C (enExample)
DE (1) DE68901097D1 (enExample)
DK (1) DK174744B1 (enExample)
ES (1) ES2032105T3 (enExample)
GR (1) GR3004461T3 (enExample)
HU (1) HU202243B (enExample)
IE (1) IE60477B1 (enExample)
PH (1) PH26819A (enExample)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1339805C (en) * 1988-01-20 1998-04-07 Yasuo Isomura (cycloalkylamino)methylenebis(phosphonic acid) and medicines containing the same as an active
IE912115A1 (en) * 1990-06-25 1992-01-01 Takeda Chemical Industries Ltd Bisphosphonic acid derivatives, their production and use
US5073339A (en) * 1990-08-23 1991-12-17 W. R. Grace & Co. - Conn Method of inhibiting corrosion and scale formation in aqueous systems
DE69116838T2 (de) * 1990-12-19 1996-06-13 Takeda Chemical Industries Ltd Bisphosphonsäurederivate, ihre Produktion und ihre Verwendung
CA2060790A1 (en) * 1991-02-07 1992-08-08 Yoshitaka Ohishi Bisphosphonic acid derivatives, their intermediates and bone resorption inhibitors containing them as active ingredients
ATE164163T1 (de) * 1991-06-19 1998-04-15 Upjohn Co Dialkyl (dialkoxyphosphinyl)methyl phosphate als antientzündungsmittel
EP0522576A3 (en) * 1991-07-12 1993-07-14 Hoechst Aktiengesellschaft Aminoethane-1,1-bisphosphonic acids and aminoethane-1,1-alkylphospinic/phosphonic acids, process of their preparation and their use
EP0541037A3 (en) * 1991-11-06 1997-02-26 Takeda Chemical Industries Ltd Squalene synthetase inhibitory composition and use thereof
US5391743A (en) * 1992-05-29 1995-02-21 Procter & Gamble Pharmaceuticals, Inc. Quaternary nitrogen-containing phosphonate compounds, pharmaceutical compositions, and methods of treating abnormal calcium and phosphate metabolism and methods of treating and preventing dental calculus and plaque
US6406714B1 (en) 1992-12-02 2002-06-18 Merck & Co., Inc. Dry mix formulation for bisphosphonic acids
US5358941A (en) * 1992-12-02 1994-10-25 Merck & Co., Inc. Dry mix formulation for bisphosphonic acids with lactose
US6399592B1 (en) 1992-12-23 2002-06-04 Merck & Co., Inc. Bishphosphonate/estrogen synergistic therapy for treating and preventing bone loss
FR2703590B1 (fr) * 1993-04-05 1995-06-30 Sanofi Elf Utilisation de derives d'acide bisphosphonique pour la preparation de medicaments destines a favoriser la reparation osseuse .
US5854227A (en) * 1994-03-04 1998-12-29 Hartmann; John F. Therapeutic derivatives of diphosphonates
US20010007863A1 (en) 1998-06-18 2001-07-12 Merck & Co., Inc. Wet granulation formulation for bisphosphonic acids
EP0831756A1 (en) 1995-06-06 1998-04-01 Merck & Co., Inc. Bisphosphonate cement composition to prevent aseptic loosening of orthopedic implant devices
US20030096760A1 (en) * 1997-03-10 2003-05-22 Smithklinebeecham Corporation Method of antagonizing the human SRC SH2 domain
IT1303672B1 (it) 1998-07-28 2001-02-23 Nicox Sa Sali nitrati di farmaci attivi nei disordini ossei
AR024462A1 (es) 1999-07-01 2002-10-02 Merck & Co Inc Tabletas farmaceuticas
KR20020059790A (ko) * 1999-11-25 2002-07-13 오노다 마사요시 치주병 치료제
US6677320B2 (en) 2000-01-20 2004-01-13 Hoffmann-La Roches Inc. Parenteral bisphosphonate composition with improved local tolerance
NZ532994A (en) * 2001-12-21 2008-05-30 Procter & Gamble Method for the treatment of bone disorders using a bisphosphonate regimen, risedronate in particular
US20050070504A1 (en) * 2001-12-21 2005-03-31 The Procter & Gamble Co. Risedronate compositions and their methods of use
CA2472578A1 (en) * 2002-01-24 2003-07-31 Yissum Research Development Company Of The Hebrew University Of Jerusalem Anti-cancer combination and use thereof
KR20140021045A (ko) 2002-05-10 2014-02-19 에프. 호프만-라 로슈 아게 골다공증 치료 및 예방용 비스포스폰산
AU2003233731A1 (en) * 2002-06-06 2003-12-22 Xavier Billot 1,5-disubstituted imidazolidin-2-one derivatives for use as ep4 receptor agonists in the treatment of eye and bone diseases
WO2004019938A1 (en) * 2002-08-28 2004-03-11 Merck Frosst Canada & Co. Oxazolidin-2-one and thiazolidin-2-one derivatives for use as ep4 receptor agonists in the treatment of glaucoma
ES2530791T3 (es) * 2002-12-20 2015-03-05 Hoffmann La Roche Formulación de ibandronato de altas dosis
JP4553899B2 (ja) 2003-08-21 2010-09-29 メルク フロスト カナダ リミテツド カテプシンシステインプロテアーゼ阻害剤
NZ545804A (en) * 2003-09-19 2009-09-25 Wisconsin Alumni Res Found Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-or-vitamin D derivatives and a bisphosphonate
US20050261250A1 (en) * 2004-05-19 2005-11-24 Merck & Co., Inc., Compositions and methods for inhibiting bone resorption
DK1753395T3 (da) 2004-05-24 2010-11-08 Warner Chilcott Co Llc Enterisk, fast, oral doseringsform af et bisphosphonat, der indeholder et chelateringsmiddel
UA87854C2 (en) 2004-06-07 2009-08-25 Мерк Энд Ко., Инк. N-(2-benzyl)-2-phenylbutanamides as androgen receptor modulators
PT1855674E (pt) 2005-03-02 2014-10-08 Merck Canada Inc Composição para a inibição de catepsina k
BRPI0606280A2 (pt) * 2005-03-17 2009-06-09 Elan Pharma Int Ltd composições de bisfosfonato nanoparticulado
CA2708281A1 (en) 2007-12-11 2009-08-27 Viamet Pharmaceuticals, Inc. Metalloenzyme inhibitors using metal binding moieties in combination with targeting moieties
EP2489656A1 (en) 2007-12-21 2012-08-22 Ligand Pharmaceuticals Inc. Selective androgen receptor modulators (sarms) and uses thereof
US20090181138A1 (en) 2008-01-11 2009-07-16 David Howard Process for producing precooked bacon slices
FR2954320B1 (fr) 2009-12-17 2012-06-15 Cll Pharma Composition pharmaceutique orale suprabiodisponible contenant un acide biphosphonique ou un de ses sels
EP2675440B1 (en) 2011-02-14 2020-03-25 Merck Sharp & Dohme Corp. Cathepsin cysteine protease inhibitors
GB201200868D0 (en) 2012-01-19 2012-02-29 Depuy Int Ltd Bone filler composition
WO2015051479A1 (en) 2013-10-08 2015-04-16 Merck Sharp & Dohme Corp. Cathepsin cysteine protease inhibitors
JP6454335B2 (ja) 2013-10-08 2019-01-16 メルク・シャープ・アンド・ドーム・コーポレーションＭｅｒｃｋ Ｓｈａｒｐ ＆ Ｄｏｈｍｅ Ｃｏｒｐ． カテプシンシステインプロテアーゼ阻害剤
WO2015120580A1 (en) 2014-02-11 2015-08-20 Merck Sharp & Dohme Corp. Cathepsin cysteine protease inhibitors
PL407922A1 (pl) 2014-04-16 2015-10-26 Wrocławskie Centrum Badań Eit + Spółka Z Ograniczoną Odpowiedzialnością Nowe bisfosfoniany i ich zastosowanie
JP6649902B2 (ja) 2014-05-30 2020-02-19 ファイザー・インク 選択的アンドロゲン受容体モジュレーターとしてのカルボニトリル誘導体
CA3133929A1 (en) 2019-04-19 2020-10-22 Lin Zhi Crystalline forms and methods of producing crystalline forms of a compound
WO2023275715A1 (en) 2021-06-30 2023-01-05 Pfizer Inc. Metabolites of selective androgen receptor modulators

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1958123C3 (de) * 1969-11-19 1978-09-28 Henkel Kgaa, 4000 Duesseldorf Verfahren zur Herstellung von 1 -Aminoalkan-1,1 -diphosphonsäuren oder deren Salzen
DE2037586C3 (de) * 1970-07-29 1980-05-22 Henkel Kgaa, 4000 Duesseldorf Gipsmassen
DE2104476C2 (de) * 1971-02-01 1983-12-01 Henkel KGaA, 4000 Düsseldorf Verfahren zur Verhinderung von Ausfällungen in Wasser oder wäßrigen Lösungen
DE3540150A1 (de) * 1985-11-13 1987-05-14 Boehringer Mannheim Gmbh Neue diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel
CA1339805C (en) * 1988-01-20 1998-04-07 Yasuo Isomura (cycloalkylamino)methylenebis(phosphonic acid) and medicines containing the same as an active
JPH01231980A (ja) * 1988-03-10 1989-09-18 Ishikawajima Harima Heavy Ind Co Ltd 管内作業用ピグ

Also Published As

Publication number Publication date
EP0325482B1 (en) 1992-04-01
GR3004461T3 (enExample) 1993-03-31
PH26819A (en) 1992-11-05
EP0325482A1 (en) 1989-07-26
DE68901097D1 (de) 1992-05-07
CN1035829A (zh) 1989-09-27
DK174744B1 (da) 2003-10-13
ATE74361T1 (de) 1992-04-15
US4970335A (en) 1990-11-13
DK24389D0 (da) 1989-01-20
AU2867089A (en) 1989-07-20
KR890011601A (ko) 1989-08-21
IE890183L (en) 1989-07-20
HU202243B (en) 1991-02-28
US5041428A (en) 1991-08-20
IE60477B1 (en) 1994-07-13
ES2032105T3 (es) 1993-01-01
AU615711B2 (en) 1991-10-10
DK24389A (da) 1989-07-21
CA1339805C (en) 1998-04-07
CN1022630C (zh) 1993-11-03
HUT50841A (en) 1990-03-28

Similar Documents

Publication Publication Date Title
KR970005179B1 (ko) (사이클로알킬아미노)메틸렌비스(포스폰산) 및 활성 성분으로서 이를 함유하는 약제
KR0156239B1 (ko) 헤테로 사이클릭 비스포스폰산 유도체 및 이의 제조방법
EP0252505B1 (de) 1-Hydroxy-3-(N-methyl-N-propylamino)propan-1,1-diphosphonsäure; Verfahren zu dessen Herstellung und diese Verbindung enthaltende Arzneimittel
US4621077A (en) Pharmacologically active biphosphonates, process for the preparation thereof and pharmaceutical compositions therefrom
JP3499905B2 (ja) グアニジンアルキル−１，１−ビスホスホン酸誘導体、その製法およびその使用
SU843746A3 (ru) Способ получени аминотиазоловили иХ КиСлОТНО-АддиТиВНыХ СОлЕй
KR0171570B1 (ko) N-헤테로사이클릭프로필리덴-1,1-비스포스폰산,이의제조방법및약제학적조성물
EP0282320B1 (en) Bisphosphonic acid derivatives and medicines containing the same
IE58614B1 (en) Derivatives of methylene-bisphosphonic acid, process f their preparation and a pharmaceutical composition
SK281788B6 (sk) Deriváty kyseliny bisfosfónovej, spôsob ich prípravy a farmaceutický prostriedok s ich obsahom
JPS637526B2 (enExample)
SU1410865A3 (ru) Способ получени производных метилендифосфоновой кислоты
SK144494A3 (en) Sulfur-containing phosphate compounds and their using in pharmaceutical compound for treating abnormal calcium and phosphate metabolism
US4929606A (en) Azacycloalkylalkanediphosphonic acids useful for treating diseases attributed to calcium metabolism disorders
JPH0699457B2 (ja) ヘテロ環ビスフォスフォン酸誘導体およびその医薬
CA1054609A (en) S-heterocyclic derivatives of phosphine or phosphite gold mercaptides
JPH07507316A (ja) 異常なカルシウムおよびホスフェート代謝を治療するためのチオ置換環式ホスホネート化合物
US4000265A (en) Method for treating arteriosclerotic and cardiovascular disorders
US4129660A (en) Derivatives of cis-epoxy-1,2-propyl-phosphonic acid and drugs containing in particular as active ingredients derivatives of cis-epoxy-1,2-propylphosphonic acid in dextrorotatory form
JPH07629B2 (ja) （シクロアルキルアミノ）メチレンビス（フォスフォン酸）および該化合物を有効成分とする医薬
EP0623623B1 (en) 2-aminoethanesulfonic acid/zinc complex
JPH0248587A (ja) 複素環置換ビスフォスフォン酸誘導体及びその医薬
US3309270A (en) Organic phosphorus anthelmintics and method of using the same
US3787568A (en) Arthritic compositions comprising an s-(phosphino-or phosphitoaurous)-thiouronium halide and method of producing anti-arthritic activity
US3911119A (en) Anti-arthritic compositions comprising large ring gold-sulfur-phosphine chelates and methods of producing anti-arthritic activity

Legal Events

Date Code Title Description
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 19890120

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 19931108

Comment text: Request for Examination of Application

Patent event code: PA02011R01I

Patent event date: 19890120

Comment text: Patent Application

G160 Decision to publish patent application
PG1605 Publication of application before grant of patent

Comment text: Decision on Publication of Application

Patent event code: PG16051S01I

Patent event date: 19970312

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 19970624

GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 19970728

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 19970728

End annual number: 3

Start annual number: 1

FPAY Annual fee payment

Payment date: 19990413

Year of fee payment: 15

PR1001 Payment of annual fee

Payment date: 19990413

Start annual number: 4

End annual number: 15

EXPY Expiration of term
PC1801 Expiration of term